Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $340.64 | $7.39 | 4,510.08% | 6,812.80x | 327.51x | 7.55x | 9.14x | 18.21x | $529.27M | 1.41% | $4.13B | 37.48 | $35.60B | 111.94 | ||
| CORT | CORCEPT THERAPEUTICS INC | $79.80 | $33.18 | 140.49% | 79.80x | 78.43x | 11.15x | 13.28x | 1.11x | $162.57M | 1.97% | $631.90M | 6.10 | $8.28B | 125.43 | ||
| NVO | NOVO NORDISK A S | $48.71 | $153.74 | -68.32% | 13.55x | 2.04x | 4.45x | 8.27x | 0.14x | $9.34B | 4.32% | $26.18B | 5.89 | $227.09B | 9.15 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $445.12 | $29.46 | 1,410.95% | 1,435.87x | 305.74x | 18.23x | 251.42x | 6.11x | $221.36M | 0.38% | $233.89M | 1.78 | $60.53B | 398.42 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.75 | $5.08 | -65.53% | 25.00x | 13.33x | 2.24x | 2.66x | 0.14x | -$11.69M | -8.40% | $52.91M | 0.67 | $135.27M | 15.25 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.60 | $11.48 | -25.11% | 17.92x | 7.01x | 5.70x | 3.64x | 0.38x | -$23.64M | -4.92% | $133.17M | 2.38 | $492.44M | 7.33 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $42.54 | $15.36 | 176.94% | 86.82x | 40.20x | 5.32x | 6.02x | 1.30x | $101.73M | 3.20% | $535.38M | 7.17 | $3.06B | 57.10 | ||
| ARGX | ARGENX SE | $917.63 | $262.11 | 250.09% | 36.67x | 54.84x | 29,600.97x | 7.81x | 3.07x | $467.72M | 0.84% | $7.17B | 117.50 | $53.60B | 66.07 | ||
| RPRX | ROYALTY PHARMA PLC | $39.84 | $42.38 | -5.99% | 22.64x | 8.69x | 7.32x | 2.39x | 0.47x | $2.11B | 12.27% | $9.62B | 22.28 | $31.00B | 29.69 | ||
| VCEL | VERICEL CORP | $40.37 | $7.40 | 445.69% | 155.27x | 179.90x | 7.88x | 6.34x | 2.62x | $20.38M | 1.00% | $321.86M | 6.38 | $2.04B | 69.57 | ||
| GMAB | GENMAB A | $31.92 | $116.44 | -72.59% | 13.62x | 1.84x | 5.75x | 3.56x | 0.12x | $1.19B | 5.83% | $5.75B | 8.96 | $18.88B | 9.43 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $206.16 | $62.50 | 229.85% | 89.25x | 29.44x | 16.07x | 4.27x | 1.60x | $30.76M | 0.76% | $950.17M | 48.53 | $4.37B | 42.41 | ||
| TECH | BIO-TECHNE CORP | $64.63 | $16.72 | 286.52% | 129.26x | 31.62x | 8.26x | 5.12x | 1.78x | $224.06M | 2.23% | $1.97B | 12.65 | $10.32B | 46.72 | ||
| KRYS | KRYSTAL BIOTECH INC | $218.70 | $85.44 | 155.98% | 31.70x | 42.93x | 16.97x | 5.57x | 1.87x | $166.02M | 2.62% | $1.14B | 39.30 | $5.96B | 30.83 | ||
| HALO | HALOZYME THERAPEUTICS INC | $72.66 | $78.20 | -7.09% | 14.86x | 11.57x | 6.85x | 16.96x | 0.56x | $602.40M | 7.07% | $503.92M | 4.30 | $9.64B | 11.40 | ||
| VCYT | VERACYTE INC | $47.71 | $9.05 | 427.34% | 122.33x | 119.42x | 7.59x | 3.00x | 2.69x | $98.21M | 2.62% | $1.26B | 15.98 | $3.49B | 61.31 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.52 | $42.66 | 30.14% | 20.41x | 18.28x | 3.45x | 1.76x | 0.79x | $832.13M | 7.80% | $6.06B | 31.54 | $10.01B | 12.96 | ||
| CRMD | CORMEDIX INC | $9.65 | $16.90 | -42.90% | 4.25x | 4.55x | 3.42x | 2.03x | 1.07x | $74.42M | 10.16% | $374.13M | 4.93 | $860.74M | 7.67 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.85 | $0.87 | 804.11% | 112.14x | 74.48x | 6.65x | 7.42x | 6.58x | $3.05M | 0.43% | $101.92M | 1.12 | $716.98M | 54.20 | ||
| EXEL | EXELIXIS INC | $44.21 | $27.72 | 59.49% | 17.97x | 18.44x | 5.19x | 5.49x | 1.28x | $779.77M | 6.57% | $2.16B | 8.05 | $11.65B | 12.56 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $35.56 | $40.34 | -11.86% | 11.01x | 10.89x | 2.48x | 2.45x | 0.64x | $296.89M | 14.51% | $835.12M | 14.51 | $1.57B | 5.82 | ||
| INVA | INNOVIVA INC | $21.71 | $18.51 | 17.29% | 11.49x | 18.24x | 3.86x | 1.61x | 1.13x | $196.54M | 13.11% | $1.01B | 14.63 | $1.40B | 6.54 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $16.37 | $7.26 | 125.51% | 28.22x | 24.75x | 8.12x | 5.90x | 1.63x | $119.87M | 5.55% | $365.77M | 2.78 | $2.16B | 20.90 | ||
| INCY | INCYTE CORP | $105.65 | $68.11 | 55.12% | 17.49x | 15.17x | 4.30x | 4.46x | 1.24x | $1.20B | 5.79% | $4.65B | 23.77 | $18.32B | 10.89 | ||
| ADMA | ADMA BIOLOGICS INC | $19.14 | $9.45 | 102.48% | 21.75x | 31.63x | 9.35x | 10.56x | 1.72x | $40.73M | 0.89% | $431.19M | 1.81 | $4.57B | 26.54 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.89 | $2.35 | 193.60% | 25.52x | 46.90x | 4.41x | 7.78x | 3.52x | $21.15M | 3.85% | $70.68M | 0.89 | $488.63M | 21.53 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $432.17 | $175.89 | 145.71% | 30.20x | 23.51x | 9.42x | 6.33x | 1.80x | $3.34B | 3.02% | $17.32B | 67.76 | $106.54B | 22.85 | ||
| UTHR | UNITED THERAPEUTICS CORP | $488.43 | $197.28 | 147.58% | 17.15x | 17.39x | 6.84x | 3.19x | 6.63x | $1.12B | 5.24% | $6.59B | 150.46 | $19.69B | 11.10 | ||
| MNKD | MANNKIND CORP | $5.38 | $1.30 | 314.23% | 53.80x | 56.81x | 5.26x | -37.08x | 2.90x | $43.39M | 2.62% | -$44.55M | -0.15 | $1.88B | 25.75 | ||
| MDXG | MIMEDX GROUP INC | $6.88 | $3.21 | 114.12% | 24.57x | 15.87x | 2.59x | 4.26x | 1.68x | $66.82M | 6.56% | $238.95M | 1.61 | $895.07M | 12.93 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $23.43 | $11.05 | 112.13% | 13.09x | 15.75x | 4.97x | 3.13x | 22.10x | $234.54M | 8.16% | $920.25M | 7.51 | $2.19B | 6.77 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $784.61 | $355.78 | 120.53% | 18.06x | 18.35x | 5.71x | 2.66x | 3.05x | $4.22B | 5.19% | $30.96B | 298.82 | $82.66B | 14.47 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.